Biotechnology Stocks
| # | Letzte 7 Tage | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1565 | LEGN Legend Biotech Corporation - American Depositary Shares | 18.73 USD | -2.04% | -3.05% | -7.37% | -41.43% | 3.46 B USD | ||
| 1570 | ACAD ACADIA Pharmaceuticals Inc. - Common Stock | 19.57 USD | -0.41% | -1.61% | -28.68% | -7.99% | 3.37 B USD | ||
| 1591 | CELC Celcuity Inc. - Common Stock | 67.90 USD | +3.22% | -9.62% | -26.20% | +38.26% | 3.32 B USD | ||
| 1607 | VKTX Viking Therapeutics, Inc. - Common Stock | 27.74 USD | -2.80% | -9.08% | -16.85% | -17.24% | 3.24 B USD | ||
| 1610 | TARS Tarsus Pharmaceuticals, Inc. - Common Stock | 72.28 USD | -1.81% | -4.21% | -16.26% | +9.42% | 3.17 B USD | ||
| 1651 | ARQT Arcutis Biotherapeutics, Inc. - Common stock | 24.49 USD | +1.32% | -3.16% | +1.83% | +15.85% | 3.08 B USD | ||
| 1659 | DYN Dyne Therapeutics, Inc. - Common Stock | 16.38 USD | +2.57% | +3.54% | -15.48% | -30.03% | 3.06 B USD | ||
| 1665 | AMLX Amylyx Pharmaceuticals, Inc. - Common Stock | 27.20 USD | -0.84% | -3.13% | -18.81% | +101.93% | 3.03 B USD | ||
| 1668 | RCUS Arcus Biosciences, Inc. Common Stock | 23.82 USD | -2.89% | -6.33% | -17.15% | +57.85% | 3.03 B USD | ||
| 1672 | DNLI Denali Therapeutics Inc. - Common Stock | 18.66 USD | -2.61% | -9.11% | -13.97% | +15.40% | 2.98 B USD | ||
| 1676 | ELVN Enliven Therapeutics, Inc. - Common Stock | 40.60 USD | -1.84% | -12.14% | -31.24% | +96.52% | 2.97 B USD | ||
| 1731 | ZLAB Zai Lab Limited - American Depositary Shares | 24.82 USD | -1.94% | -2.67% | -2.09% | -7.01% | 2.79 B USD | ||
| 1740 | PGEN Precigen, Inc. - Common Stock | 7.59 USD | +0.66% | -7.55% | +10.80% | +137.93% | 2.72 B USD | ||
| 1787 | NAMS NewAmsterdam Pharma Company N.V. - Ordinary Shares | 21.26 USD | -3.93% | -12.11% | -16.13% | -41.38% | 2.54 B USD | ||
| 1789 | BEAM Beam Therapeutics Inc. - Common Stock | 24.59 USD | -0.73% | +0.82% | -7.73% | -9.43% | 2.54 B USD | ||
| 1797 | LQDA Liquidia Corporation - Common Stock | 27.99 USD | +4.91% | 0.00% | -58.47% | +23.85% | 2.51 B USD | ||
| 1845 | NRIX Nurix Therapeutics, Inc. - Common stock | 22.19 USD | -2.38% | -4.93% | -16.07% | +97.95% | 2.30 B USD | ||
| 1846 | IRON Disc Medicine, Inc. - Common Stock | 60.75 USD | -0.70% | -4.50% | -20.64% | -13.56% | 2.33 B USD | ||
| 1848 | ADMA ADMA Biologics Inc - Common Stock | 10.33 USD | +1.87% | +4.03% | +9.08% | -29.30% | 2.31 B USD | ||
| 1850 | HRMY Harmony Biosciences Holdings, Inc. - Common Stock | 39.61 USD | +0.69% | +0.10% | -5.71% | +28.19% | 2.31 B USD |
Nachrichten Biotechnology Stocks
Kymera Therapeutics: Raymond James startet Coverage mit „Outperform“-Rating
Raymond James startet Coverage für Nektar-Aktie mit "Market Perform"
Raymond James nimmt Coverage für Palisade Bio mit "Outperform" auf
Raymond James bestätigt Liquidia-Rating trotz rechtlicher Unsicherheiten
Ginkgo Bioworks gewährt NSF X-Labs Zugang zu autonomem Labor
AbCellera präsentiert Phase-1/2-Daten zu Medikamentenkandidaten gegen Menopause-Beschwerden
Quantum-Si: Nachweis von 19 Aminosäuren markiert wichtigen Meilenstein für Proteus-Plattform
Gainers Biotechnology Stocks
GRDX GridAI Technologies Corp. - Common Stock | 4.79 | +16.26% |
CLGN CollPlant Biotechnologies Ltd. - Ordinary Shares | 3.97 | +14.74% |
IPSC Century Therapeutics, Inc. - Common Stock | 1.46 | +14.06% |
ADCT ADC Therapeutics SA Common Shares | 1.59 | +11.97% |
CDTTW CDT Equity Inc. - Warrant | 0.0117 | +11.43% |
SRZN Surrozen, Inc. - Common Stock | 28.00 | +11.38% |
ANL Adlai Nortye Ltd - American Depositary Shares | 15.54 | +10.60% |
QNCX Quince Therapeutics, Inc. - Common Stock | 29.36 | +9.88% |
Losers Biotechnology Stocks
SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0088 | -27.87% |
YDESW YD Bio Limited - Warrants | 0.5000 | -23.08% |
CRBU Caribou Biosciences, Inc. - Common Stock | 0.48 | -22.58% |
TCRX TScan Therapeutics, Inc. - Common Stock | 0.23 | -17.86% |
KALA KALA BIO, Inc. - Common Stock | 0.30 | -16.67% |
BRTX BioRestorative Therapies, Inc. - Common Stock | 1.89 | -15.62% |
ENLV Enlivex Ltd. - Ordinary Shares | 0.27 | -12.90% |
MLEC Moolec Science SA - Ordinary Shares | 4.19 | -12.89% |